Craspase is a newly identified Type III CRISPR-Cas system with two major components: Cas7-11 with nuclease activity and TPR-CHAT with protease activity. Craspases perform a delicate balancing act between nuclease and protease activity to achieve immune tolerance and immune defense in bacteria. See Ekundayo et al.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11332594 | PMC |
| http://dx.doi.org/10.1038/s41594-022-00917-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rational engineering of minimally immunogenic nucleases for gene therapy.
Nat Commun
January 2025
Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
Genome editing using CRISPR-Cas systems is a promising avenue for the treatment of genetic diseases. However, cellular and humoral immunogenicity of genome editing tools, which originate from bacteria, complicates their clinical use. Here we report reduced immunogenicity (Red)(i)-variants of two clinically relevant nucleases, SaCas9 and AsCas12a.
View Article and Find Full Text PDFA dual-switch electrochemical aptasensor for label-free detection of thrombin and ATP based on split aptamers.
Anal Chim Acta
January 2025
Hubei Key Laboratory for Precision Synthesis of Small Molecule Pharmaceuticals & Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430062, PR China. Electronic address:
Background: Aptamers, consisting of specialized single-stranded nucleic acids, are engineered through the SELEX technique to recognize specific targets with strong affinity. Aptamers are exceptionally useful in various sensor technologies, such as fluorescence-based sensors, electrochemical sensors, and colorimetric detection systems. Due to its high sensitivity, specificity and fast response, electrochemical aptasensor shows great application prospects in analytical detection, food safety, and environmental monitoring.
View Article and Find Full Text PDFHow much do we know about nanobacteria?
Ecotoxicol Environ Saf
December 2024
Acibadem Mehmet Ali Aydınlar University, Institute of Health Sciences, Department of Medical Biotechnology, Istanbul, Turkey; Acibadem Mehmet Ali Aydınlar University, School of Medicine, Department of Medical Microbiology, Istanbul, Turkey. Electronic address:
Background/purpose: Nanobacteria, known to date as self-replicating, nano-scale size organisms, smaller than bacteria. However, whether these are living organisms or agglomeration of biomolecules was one of the most controversial issues for many years. One of the reasons for debate is their lack of any genetic material.
View Article and Find Full Text PDFThe ability of to limit protease production plays a key role in the pathogenesis of osteomyelitis irrespective of the functional status of .
Infect Immun
November 2024
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Article Synopsis
- - The study shows that mutating the staphylococcal accessory regulator A (sarA) in the USA300 strain LAC significantly reduces virulence in a mouse model for osteomyelitis more effectively than altering the accessory gene regulator (agr), regardless of the status of another gene (likely referring to a specific gene related to virulence).
- - The researchers found that protease production decreased in the sarA mutant, whereas it increased in the agr and another mutant; these changes affected biofilm formation and cytotoxicity of conditioned medium (CM) against bone cells.
- - The research concluded that increased production of extracellular proteases limits the effectiveness of key virulence factors, such as toxins, thereby reducing the overall virulence
Rabies virus-mimicking liposomes for targeted gene therapy in Alzheimer's disease.
Int J Pharm
January 2025
Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, 35620 Izmir, Turkey.
RNA interference (RNAi) harbors significant potential for treating neurological disorders; nevertheless, limited efficacy has been discerned. The presence of barriers within the central nervous system, coupled with the inherent instability of nucleic acids within biological conditions, poses formidable challenges in advancing effective gene delivery strategies. In this study, we designed and prepared a virus-mimic non-viral gene vector, rabies virus glycoprotein (RVG29)-decorated liposome (f(Lipo)-RVG29), to deliver small interfering RNAs to the brain.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!